Carazolol

Carazolol
Clinical data
ATC code	C07 (WHO) ;
Identifiers
	IUPAC name 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol;
CAS Number	57775-29-8;
PubChem CID	71739;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C18H22N2O3
Molar mass	298.38

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.^[1]

References

↑ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. PMID 41147.

Carazolol at the US National Library of Medicine Medical Subject Headings (MeSH)

Clinical data

ATC code	C07 (WHO)
Identifiers
IUPAC name 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
CAS Number	57775-29-8
PubChem CID	71739
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₈H₂₂N₂O₃
Molar mass	298.38